Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
There is a role for imaging in managing CLL when there is an indication, but no role for “routine” imaging as Dr. Lamanna explains at iwCLL 2019 in Scotland in the article by Tom Henry, the CLL Society’s pharmacist.
CLL Society Patient Education Forum at the City of Hope, January 11, 2020 The CLL Society partnered with featured speakers from the City of Hope to present the very latest advances
Dr. Brian Koffman, the Executive Vice President (EVP) and Chief Medical Officer (CMO) of the CLL Society, counts down his top ten CLL related abstract from ASCO or the American Society
Dr. Susan O’Brien moved from MD Anderson to head up the CLL research and clinical team at the University of California at Irvine (UCI), and we chronic lymphocytic patients in southern
Great progress has been made in treating chronic lymphocytic leukemia, but sadly the outcomes for Richter’s Transformation (RT)) or Richter’s Syndrome (RS) remain dismal. For more basic information on RT aka
Dr. Rick Furman of Weill Cornell, in NYC has a long and deep experience treating CLL with novel therapies. At ASH 2018, I interviewed Dr. Furman on how to best use
By Alan Skarbnik, MD The landscape of CLL is changing fast. Novel therapies and combinations are being studied and approved at a significant pace. Venetoclax is a very potent anti-CLL agent that’s
By Brian Koffman, MD There are many prognostic and predictive tests that can be ordered at different times on our CLL journey. Let’s start by saying that there is no consensus
At ASH 2018 in San Diego, CA, I interviewed Dr. Neil Kay out of Mayo Clinic, Rochester, MN, an innovative chronic lymphocytic leukemia researcher who besides caring for CLL patients and
One click to our most popular content.
